Eyenovia raises $50M to acquire HYPE tokens, shifts to crypto treasury strategy; appoints new CIO

HYPERION DEFI, INC.

$50M PIPE for HYPE tokens; warrants could raise ~$150M more if exercised at $3.25/share.
Hyunsu Jung appointed CIO and board member; three directors resigned per investor agreement.
Loan amended: maturity extended to July 2028, interest rate cut to 8% (half PIK), interest-only through Jan 2027.
Company expects to rename to Hyperion DeFi and change ticker to HYPD.
Gen-2 Optejet device still in development; FDA registration anticipated by September 2025.

item 1.01item 5.03item 2.03item 3.02item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sean Ianchulev

Director

HYPD · HYPERION DEFI, INC.

Effective: 2025-06-17
Filed: Jun 24, 2025 23:59 UTC

On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.

Appointed

Hyunsu Jung

Chief Investment Officer

HYPD · HYPERION DEFI, INC.

Effective: 2025-06-17
Filed: Jun 24, 2025 23:59 UTC

On June 17, 2025, the Board of Directors (the “Board”) of the Company appointed Hyunsu Jung to the position of Chief Investment Officer and to serve on the Board, effective immediately.

Departed

Ram Palanki

Director

HYPD · HYPERION DEFI, INC.

Effective: 2025-06-17
Filed: Jun 24, 2025 23:59 UTC

On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.

Departed

Charles Mather IV

Chair

HYPD · HYPERION DEFI, INC.

Effective: 2025-06-17
Filed: Jun 24, 2025 23:59 UTC

On June 17, 2025, Sean Ianchulev, M.D., Charles Mather IV (Chair) and Ram Palanki, Pharm. D., resigned from the Board and their respective positions on the committees of the Board.

Source: SEC EDGAR

accession 0001104659-25-062095

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.